Vertex Pharmaceuticals Inc <VRTX.O>: Bofa Global Research Raises Price Objective To $605 From $600
VRTX•Related News
Johnson & Johnson names Tom Cavanaugh EVP, worldwide chairman of Innovative Medicine as Taubert retires
JNJ•
Burke & Herbert Financial Services director David Wilson acquires 100 common shares worth $7,368
BHRB•
Wave Life Sciences CEO to speak at BofA Securities SMID Cap Executive Insights event
WVE•
BBVA completes EUR 3.96 billion extraordinary share buyback program
BBVA•
US trade deficit contracts in June
SPY•